bioRxivImmunologyPreprint
Gut bacterium of Leishmania donovani-non-transmitting sand fly induces IL-23~Th17 axis to protect hosts from drug-resistant visceral leishmaniasis
Suman KarmakariD, Pritam MandaliD, Supriya NathiD, Soumyadip MukherjeeiD, Kamalika RoyiD, Mintu KaraniD, Sharmistha Paul, Sondipon ChakrabortyiD, Ashif Ali Sardar, Mithun SarkariD, Pradyumna PatraiD, Chiranjib PaliD
Abstract
Background: Visceral leishmaniasis (VL) is caused by Leishmania donovani and differentiates under the influence of biotope-specific gut bacteria in the Leishmania donovani-transmitting sand fly vector, Phlebotomus argentipes, which coexists with the Leishmania donovani-non-transmitting Sergentomyia species in the Indian subcontinent. Hypothesis: Sergentomyia are primarily herpetophilic. Interestingly, we identified a specific population of anthropophilic Sergentomyia babu babu, a proven naturally non-competent vector for transmitting Leishmania donovani, with high abundance and human-bite incidences in VL-non-endemic regions, compared with VL-endemic regions of India. Thus, the possibility of egesting gut bacteria to humans from VL-non-transmitting Sergentomyia and inducing downstream immune cascades remains undeniable. Innovation: We characterized gut bacteria from anthropophilic Sergentomyia babu babu in both VL-endemic and VL-non-endemic regions of India and found that a heat-inactivated formulation of Heyndrickxia sporothermodurans [NCBI Sequence Read Archive (SRA): PRJNA1403236], isolated from anthropophilic Sergentomyia babu babu from a VL-non-endemic region, prevented and cured L. donovani infection by inducing IL-23~Th17. More importantly, it also prevented the initial parasite establishment by inducing phagocytosis, ROS, and TNF- in circulatory Ly6G-CD11b+Ly6Chi monocytes. To the best of our knowledge, this is the first report confirming that the gut bacteria of VL-non-transmitting sand flies are critical and need to be investigated in depth for developing therapeutics and/or prophylactics against visceral leishmaniasis (VL), and suggests that possible bite-transfer of gut bacteria from disease-non-transmitting vectors to hosts may restrict disease pathogenicity. Further clinical trials are needed to warrant (Indian patent: 202511041013, April 28, 2025).
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Molecular detection of Leishmania donovani, Leishmania major, and Trypanosoma spp. in Sergentomyia squamipleuris sandflies from a visceral leishmaniasis focus in Merti sub-County, eastern Kenya
Barrack O. Owino, Milkah Mwangi, … Damaris Matoke-Muhia·Parasites & VectorsPeer-reviewed·Jan 18, 2021
- Leishmania infantum xenodiagnosis from vertically infected dogs reveals significant skin tropism
B. M. Scorza, K. G. Mahachi, … C. A. Petersen·bioRxiv·Apr 8, 2021
- Odour of domestic dogs infected with Leishmania infantum is attractive to female but not male sand flies: evidence for parasite manipulation.
M. Staniek, J. G. Hamilton·bioRxiv·Nov 9, 2020
- Wnt5A Signaling Blocks Progression of Experimental Visceral Leishmaniasis
S. Maity, A. Chakraborty, … M. Sen·bioRxiv·Nov 12, 2021
- Bi-directional highways and super-seeder tissues underpin parasite dissemination in experimental visceral leishmaniasis.
Ciara F. Loughrey, Juliana B. T. Carnielli, … Paul Martin Kaye·bioRxiv·Dec 30, 2025
- Preclinical validation of a second generation leishmanization vaccine against vector transmitted fatal visceral leishmaniasis
H. L. Nakhasi, R. DEY, … K. Pandey·bioRxiv·Nov 18, 2020